grantDOI: https://doi.org/10.48105/pc.gr.146717 studyName: Exploiting cytotoxic role of nuclear Rac1 to develop targeted antitumor therapy of NF2-associated tumor dataStatus: Under Embargo initiative: Young Investigator Award studyLeads: Filipp Kulikov studyStatus: Completed diseaseFocus: Neurofibromatosis type 2 institutions: Pirogov Russian National Research Medical University fundingAgency: CTF manifestation: Schwannoma Meningioma relatedStudies: syn35632706 syn27261829 syn27761862 syn51907739 studyFileviewId: syn26383477 syn26383474 syn26383475 syn26383477 syn26383476
Drop files to upload
Exploiting cytotoxic role of nuclear Rac1 to develop targeted antitumor therapy of NF2-associated tumors page is loading…